CN106109577A - A kind of poultry compound medicine containing Cortex Cinnamomi and sulfamonomethoxine sodium - Google Patents

A kind of poultry compound medicine containing Cortex Cinnamomi and sulfamonomethoxine sodium Download PDF

Info

Publication number
CN106109577A
CN106109577A CN201610704857.0A CN201610704857A CN106109577A CN 106109577 A CN106109577 A CN 106109577A CN 201610704857 A CN201610704857 A CN 201610704857A CN 106109577 A CN106109577 A CN 106109577A
Authority
CN
China
Prior art keywords
cortex cinnamomi
sulfamonomethoxine sodium
sodium
sulfamonomethoxine
compound medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201610704857.0A
Other languages
Chinese (zh)
Inventor
不公告发明人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangxi University
Original Assignee
Guangxi University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangxi University filed Critical Guangxi University
Priority to CN201610704857.0A priority Critical patent/CN106109577A/en
Publication of CN106109577A publication Critical patent/CN106109577A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/70Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in livestock or poultry

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)

Abstract

The present invention relates to a kind of poultry compound medicine containing Cortex Cinnamomi and sulfamonomethoxine sodium, be made up of sulfamonomethoxine sodium and Cortex Cinnamomi, the weight ratio of sulfamonomethoxine sodium and Cortex Cinnamomi is 1:5 1:30.Described sulfamonomethoxine sodium and the weight ratio of Cortex Cinnamomi are preferably 1:30.The present invention is also claimed by the compound preparation become prepared by above-mentioned poultry compound medicine.The present invention possesses and provides the benefit that: proving through experimental study, sulfamonomethoxine sodium is used in combination with specific part by weight with Cortex Cinnamomi, has synergism obvious, and curative effect is fast, low cost and other advantages.

Description

A kind of poultry compound medicine containing Cortex Cinnamomi and sulfamonomethoxine sodium
Technical field
The invention belongs to poultry compound medicine technical field, particularly relate to a kind of containing Cortex Cinnamomi and sulfamonomethoxine sodium Poultry compound medicine, infected, by colon bacillus, the disease that causes for treating poultry.
Background technology
After poultry are infected by colon bacillus, the multiple locations such as acute sepsis, peritonitis, hepatitis, pneumonia, enteritis can be caused Severe infections, causes huge economic loss to livestock and poultry cultivation.Sulfamonomethoxine sodium, norfloxacin, florfenicol etc. are Preventing and treating the conventional Western medicine of this type of disease, along with medication is more and more spread unchecked, its Resistant strain is the most, and drug cost is the most increasingly Greatly, but therapeutic effect and drug resistance situation are not taken a turn for the better, and go from bad to worse on the contrary.
Through retrieval, do not inquire and Cortex Cinnamomi and sulfamonomethoxine sodium are combined for treating poultry by E Bacterium infects the relevant report of the disease caused.
Summary of the invention
The technical problem to be solved in the present invention is to provide a kind of poultry compound recipe containing Cortex Cinnamomi and sulfamonomethoxine sodium Medicine, its synergism is obvious, it is possible to eliminate the colon bacillus drug resistance to sulfamonomethoxine sodium, improves treatment effect Really.
For solving above technical problem, the present invention by the following technical solutions: a kind of containing Cortex Cinnamomi and sulfamonomethoxine The poultry compound medicine of sodium, is made up of sulfamonomethoxine sodium and Cortex Cinnamomi, sulfamonomethoxine sodium and the weight of Cortex Cinnamomi Ratio is 1:5-1:30.
Described sulfamonomethoxine sodium and the weight ratio of Cortex Cinnamomi are preferably 1:30.
The present invention is also claimed by the compound preparation become prepared by above-mentioned poultry compound medicine.
The present invention possesses and provides the benefit that: prove through experimental study, and sulfamonomethoxine sodium and Cortex Cinnamomi are with specifically Part by weight is used in combination, and has synergism obvious, and curative effect is fast, low cost and other advantages.
Detailed description of the invention
Below in conjunction with specific embodiment, technical scheme and beneficial effect are described further, except Special Statement Outward, Cortex Cinnamomi weight of the present invention is the dry weight of Cortex Cinnamomi.
One, the Cortex Cinnamomi mensuration to the drug resistance elimination effect of sulfamonomethoxine sodium
1. assay method
It is the mixing medicine that 1:1,1:3,1:5,1:10,1:30,1:50 prepare Cortex Cinnamomi and various Western medicine respectively according to weight ratio Liquid;Choose the bacterial strain to Western medicine drug resistance as subjects, utilize plate dilution method to carry out Secondary Culture, measure each process medicinal liquid MIC situation of change to Resistant strain;Set the Western medicine being not added with Cortex Cinnamomi to compare as sun, if it is right as the moon to be not added with Cortex Cinnamomi and Western medicine simultaneously According to.
Above-mentioned process was cultivated for 4 generations the most continuously.
2. result of the test
After cultivating for 4 generations continuously, the process flat board of cloudy comparison is long bacterium, and other each medicaments and admixing medical solutions are for large intestine angstrom The result statistics of the MIC of uncommon Salmonella is as shown in table 1:
As seen from the above table, when the weight ratio of sulfamonomethoxine sodium Yu Cortex Cinnamomi is 1:5, sulfamonomethoxine sodium pair The minimal inhibitory concentration of drug resistance colon bacillus reduces more than 32 times, when weight ratio is 1:10, and sulfamonomethoxine sodium pair The minimal inhibitory concentration of drug resistance colon bacillus all reduces more than 256 times, when weight ratio is 1:30, and sulfamonomethoxine sodium The minimal inhibitory concentration of drug resistance colon bacillus is all reduced more than 512 times, it is seen then that between drug resistance colon bacillus is to sulfanilamide The drug resistance of Sulfamonomethoxine sodium substantially reduces.
And when the weight ratio of sulfamonomethoxine sodium Yu Cortex Cinnamomi is 1:1,1:3 and 1:50, sulfamonomethoxine sodium To the minimal inhibitory concentration of drug resistance colon bacillus compared with the sun comparison being not added with Cortex Cinnamomi, there is no significant change.
Two, the experiment in vitro that sulfamonomethoxine sodium and Cortex Cinnamomi are used in combination
It is 1:5 mixing by sulfamonomethoxine sodium and Cortex Cinnamomi (powder) according to weight ratio, makes powder, as test group; Separately set sulfamonomethoxine sodium single dose and Cortex Cinnamomi single dose as a control group 1 and matched group 2.
Subjects is the chicken group making a definite diagnosis and having infected E.coli from chickens disease.
Morbidity chicken group is divided into 3 groups of administrations.Test group is administered according to the addition of 1g/kg feedstuff, and matched group 1 is used between sulfanilamide Sulfamonomethoxine sodium single dose is administered according to the addition of 0.2g/kg feedstuff, and matched group 2 is with Cortex Cinnamomi single dose adding according to 1g/kg feedstuff Dosage is administered;The equal SM of each group 5 days.
Result of the test: the sick chicken feed intake of test group increased, without dead, after using 5 days, chicken group can fully recover;Comparison Chicken group's great majority still wan of group 1, has the sick chicken death of 5%;Chicken group's great majority of matched group 2 are also still wans, have The sick chicken death of 14%.

Claims (3)

1. one kind contains Cortex Cinnamomi and the poultry compound medicine of sulfamonomethoxine sodium, it is characterised in that phonetic by methoxy between sulfanilamide Pyridine sodium and Cortex Cinnamomi composition, the weight ratio of sulfamonomethoxine sodium and Cortex Cinnamomi is 1:5-1:30.
Poultry compound medicine containing Cortex Cinnamomi and sulfamonomethoxine sodium the most according to claim 1, it is characterised in that Described sulfamonomethoxine sodium and the weight ratio of Cortex Cinnamomi are 1:30.
3. by the compound preparation become prepared by the poultry compound medicine described in claim 1 or 2.
CN201610704857.0A 2016-08-22 2016-08-22 A kind of poultry compound medicine containing Cortex Cinnamomi and sulfamonomethoxine sodium Withdrawn CN106109577A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610704857.0A CN106109577A (en) 2016-08-22 2016-08-22 A kind of poultry compound medicine containing Cortex Cinnamomi and sulfamonomethoxine sodium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610704857.0A CN106109577A (en) 2016-08-22 2016-08-22 A kind of poultry compound medicine containing Cortex Cinnamomi and sulfamonomethoxine sodium

Publications (1)

Publication Number Publication Date
CN106109577A true CN106109577A (en) 2016-11-16

Family

ID=57274032

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610704857.0A Withdrawn CN106109577A (en) 2016-08-22 2016-08-22 A kind of poultry compound medicine containing Cortex Cinnamomi and sulfamonomethoxine sodium

Country Status (1)

Country Link
CN (1) CN106109577A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103948691A (en) * 2014-05-14 2014-07-30 广西大学 Red paeonia/sulfamonomethoxine sodium-containing compound medicine for livestock and fowl
CN103961401A (en) * 2013-03-18 2014-08-06 广西大学 Compound medicine comprising herba lycopi and sulfamonomethoxine sodium and used for livestock and poultry
CN103989729A (en) * 2014-05-28 2014-08-20 广西大学 Acalypha australis L. and sulfamonomethoxine sodium containing compound medicine for livestock and poultry

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103961401A (en) * 2013-03-18 2014-08-06 广西大学 Compound medicine comprising herba lycopi and sulfamonomethoxine sodium and used for livestock and poultry
CN103948691A (en) * 2014-05-14 2014-07-30 广西大学 Red paeonia/sulfamonomethoxine sodium-containing compound medicine for livestock and fowl
CN103989729A (en) * 2014-05-28 2014-08-20 广西大学 Acalypha australis L. and sulfamonomethoxine sodium containing compound medicine for livestock and poultry

Similar Documents

Publication Publication Date Title
CN106138318A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and amoxicillin
CN106176897A (en) A kind of poultry compound medicine containing Herba Euphorbiae Humifusae and LIJUNJING
CN106109638A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and LIJUNJING
CN106109549A (en) A kind of poultry compound medicine containing Herba Euphorbiae Humifusae and norfloxacin
CN106138320A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and norfloxacin
CN106109577A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and sulfamonomethoxine sodium
CN106139121A (en) A kind of poultry compound medicine containing Cortex Cinnamomi, Fructus Rosae Laevigatae and colistin
CN106266049A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and sulfamonomethoxine sodium
CN106176894A (en) A kind of poultry compound medicine containing Herba Euphorbiae Humifusae and sulfamonomethoxine sodium
CN106109578A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and amoxicillin
CN106176895A (en) A kind of poultry compound medicine containing Herba Euphorbiae Humifusae and amoxicillin
CN106176943A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and LIJUNJING
CN106176942A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and norfloxacin
CN106214742A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and ceftiofur sodium
CN106176941A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and florfenicol
CN106177904A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and colistin
CN106109548A (en) A kind of poultry compound medicine containing Herba Euphorbiae Humifusae and florfenicol
CN106267152A (en) A kind of poultry compound medicine containing Herba Euphorbiae Humifusae and colistin
CN106176944A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and amikacin
CN106166176A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and fosfomycin
CN106267153A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and colistin
CN106138319A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and florfenicol
CN106166184A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and amikacin
CN106176896A (en) A kind of poultry compound medicine containing Herba Euphorbiae Humifusae and amikacin
CN106109547A (en) A kind of poultry compound medicine containing Herba Euphorbiae Humifusae and fosfomycin

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20161116